An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis - Melum, E; Karlsen, T H; Bergquist, A (The American journal of gastroenterology, 2008)
; author reply 6